Potential functional role of plasmacytoid dendritic cells in cancer immunity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Immunology

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2567.2007.02579.xPMID 17371541PMCID PMC2265944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• pro-inflammatory responses

  2007cited by this paper
• Modifying toll-like receptor 9 signaling for therapeutic use.

  2006cited by this paper
• IL-10-producing macrophages preferentially clear early apoptotic cells.

  2006cited by this paper
• Inverse correlation between CD4+ regulatory T‐cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus

  2006cited by this paper
• How TCRs bind MHCs, peptides, and coreceptors.

  2006cited by this paper
• Accelerated Macrophage Apoptosis Induces Autoantibody Formation and Organ Damage in Systemic Lupus Erythematosus1

  2006cited by this paper
• Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

  2005cited by this paper
• Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation

  2005cited by this paper
• Impaired clearance of dying cells in systemic lupus erythematosus.

  2005cited by this paper
• Targeted therapy against Bcl-2-related proteins in breast cancer cells

  2005cited by this paper
• Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses

  2005cited by this paper
• Thymic regulatory T cells.

  2005cited by this paper
• Structure, chromosomal localization, and expression of 12 genes of the MAGE family

  2005cited by this paper
• Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788

  2005cited by this paper
• Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1

  2005cited by this paper
• Migration of Dendritic Cells

  2005cited by this paper
• Understanding the generation and function of memory T cell subsets.

  2005cited by this paper
• Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells

  2005cited by this paper
• CpG motif acts as a ‘danger signal’ and provides a T helper type 1‐biased microenvironment for DNA vaccination

  2005cited by this paper
• Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization.

  2005cited by this paper
• Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

  2005cited by this paper
• Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.

  2005cited by this paper
• Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells

  2005cited by this paper
• Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.

  2005cited by this paper
• Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes

  2005cited by this paper
• Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells1

  2005cited by this paper
• Dendritic cells: limited potential in immunotherapy.

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.

  2004cited by this paper
• Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

  2004cited by this paper
• Tumor-host immune interactions and dendritic cell dysfunction.

  2004cited by this paper
• Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9

  2004cited by this paper
• Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

  2004cited by this paper
• Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells1

  2004cited by this paper
• Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils

  2004cited by this paper
• Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

  2004cited by this paper
• Central and peripheral autoantigen presentation in immune tolerance

  2004cited by this paper
• Endogenous ligands of Toll‐like receptors

  2004cited by this paper
• Activation of dendritic cells: translating innate into adaptive immunity.

  2004cited by this paper
• Dendritic cell-mediated T cell polarization

  2004cited by this paper
• Dendritic cells: sentinels against pathogens.

  2004cited by this paper
• Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL‐12 and IFN‐α production

  2004cited by this paper
• Self-representation in the thymus: an extended view

  2004cited by this paper
• Activation of autoreactive B cells by CpG dsDNA.

  2003cited by this paper
• Dealing with death: HMGB1 as a novel target for cancer therapy.

  2003cited by this paper
• Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.

  2003cited by this paper
• Lymphocyte-mediated cytotoxicity.

  2003cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• Dendritic Cells

  2003cited by this paper
• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

  2003cited by this paper
• Antigen presentation to naive CD4 T cells in the lymph node

  2003cited by this paper
• Role of Toll-Like Receptors in Pathogen Recognition

  2003cited by this paper
• Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation.

  2003cited by this paper
• Induction of immune tolerance by dendritic cells: Implications for preventative and therapeutic immunotherapy of autoimmune disease

  2002cited by this paper
• Immunologic mechanisms of antitumor activity.

  2002cited by this paper
• Myeloma and the newly diagnosed patient: a focus on treatment and management.

  2002cited by this paper
• Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

  2002cited by this paper
• The Danger Model: A Renewed Sense of Self

  2002cited by this paper
• Analysis of HLA expression in human tumor tissues

  2002cited by this paper
• Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

  2002cited by this paper
• Antitumor Effect of G3139 Bcl-2 Antisense Oligonucleotide Is Independent of Its Immune Stimulation by CpG Motifs in SCID Mice

  2002cited by this paper
• Immature myeloid cells and cancer-associated immune suppression

  2002cited by this paper
• Toll‐like receptor 9 mediates CpG‐DNA signaling

  2002cited by this paper
• Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

  2001cited by this paper
• A Role for Calnexin in the Assembly of the MHC Class I Loading Complex in the Endoplasmic Reticulum1

  2001cited by this paper
• Endotoxin-Induced Maturation of MyD88-Deficient Dendritic Cells1

  2001cited by this paper
• Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.

  2001cited by this paper
• Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo1

  2000cited by this paper
• The Dendritic Cell Receptor for Endocytosis, Dec-205, Can Recycle and Enhance Antigen Presentation via Major Histocompatibility Complex Class II–Positive Lysosomal Compartments

  2000cited by this paper
• A new era for cancer immunotherapy based on the genes that encode cancer antigens.

  1999cited by this paper
• Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

  1999cited by this paper
• CD28/CTLA-4 and CD80/CD86 families

  1999cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

  1998cited by this paper
• Characterization of human colon cancer antigens recognized by autologous antibodies

  1998cited by this paper
• A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.

  1997cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitro

  1996cited by this paper
• [Phase II study].

  1995cited by this paper
• Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.

  1995cited by this paper
• Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cells

  1994cited by this paper
• Tolerance, danger, and the extended family.

  1994cited by this paper
• Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

  1994cited by this paper
• Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene.

  1993cited by this paper
• Lymphocyte-mediated cytotoxicity.

  1987cited by this paper

• Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer

  2025cites this paper
• Harnessing DNA for Immunotherapy: Cancer, Infectious Diseases, and Beyond

  2022cites this paper
• Lipid Metabolism and Tumor Antigen Presentation.

  2021cites this paper
• Snail mucus suppresses anti dsDNA antibodies in lupus mice

  2021cites this paper
• The hepatic microenvironment and regulatory T cells.

  2020cites this paper
• Drug Delivery System Based on pH-Sensitive Biocompatible Poly(2-vinyl pyridine)-b-poly(ethylene oxide) Nanomicelles Loaded with Curcumin and 5-Fluorouracil

  2020cites this paper
• Culture supernatants of oral cancer cells induce impaired IFN-α production of pDCs partly through the down-regulation of TLR-9 expression.

  2018cites this paper
• Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.

  2017cites this paper
• The novel mitochondria‐targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthotopic model of pancreatic cancer

  2016cites this paper
• Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.

  2015cites this paper
• Tumor-Induced Immune Suppression

  2014cites this paper
• VEGF expression, microvessel density and dendritic cell decrease in thyroid cancer

  2014cites this paper
• Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma

  2014cites this paper
• Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.

  2014cites this paper
• Immunobiology of Dendritic Cells in Cancer

  2014cites this paper
• Membrane Transfer from Tumor Cells Overcomes Deficient Phagocytic Ability of Plasmacytoid Dendritic Cells for the Acquisition and Presentation of Tumor Antigens

  2014cites this paper
• TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells

  2014cites this paper
• Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.

  2014cites this paper
• TLR 7 Ligand Augments GM-CSF – Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells

  2014cites this paper
• Numerical defect of circulating dendritic cell subsets and defective dendritic cell generation from monocytes of patients with advanced melanoma.

  2013cites this paper
• Monitoring immune responses in dendritic cell based vaccination with a focus on in vivo imaging

  2013cites this paper
• Deciphering and reversing tumor immune suppression.

  2013cites this paper
• Characterising receptors for the chemokine CCL2, and their differential expression on dendritic cell subsets

  2013cites this paper
• Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.

  2012influential citation
• Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2/neu overexpressing tumor model

  2011cites this paper
• The expression and role of CXC chemokines in colorectal cancer.

  2011influential citation
• Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration.

  2010cites this paper
• Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer.

  2010cites this paper
• T Lymphocyte Infiltration Antitumoral Immune Response by Promoting Dendritic Cell Inactivation of Junctional Adhesion Molecule-A Enhances

  2010cites this paper
• Human Plasmacytoid Dendritic Cells Phagocytose, Process, and Present Exogenous Particulate Antigen

  2010cites this paper
• Dysfunctional Plasmacytoid Dendritic Cells but not NK cells in the Peripheral Blood of Stage IV Melanoma Patients

  2010cites this paper
• Anti-tumor Immunity and Mechanism of Immunosuppression Mediated by Tumor Cells: Role of Tumor-Derived Soluble Factors and Cytokines

  2010cites this paper
• Trafficking properties of plasmacytoid dendritic cells in health and disease.

  2010cites this paper
• Particulate Antigen ExogenousPhagocytose , Process , and Present Human Plasmacytoid Dendritic Cells

  2010cites this paper
• A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells

  2010cites this paper
• Natural killer cells require selectins for suppression of subcutaneous tumors.

  2009cites this paper
• Caractérisation des altérations fonctionnelles des cellules dendritiques plasmacytoïdes et myéloïdes dans les tumeurs mammaires murines

  2009cites this paper
• CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti‐CD22 antibodies to peripheral blood dendritic cells

  2009cites this paper
• Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer

  2009cites this paper
• Lymphoma microenvironment: culprit or innocent?

  2008cites this paper
• Dendritic cell vaccines in melanoma: from promise to proof?

  2008cites this paper
• Tumor microenvironment and immune escape.

  2007cites this paper
• Mécanisme d'action et fonction d'une sous-population de cellules dendritiques cytotoxiques chez le rat

  2007cites this paper
• Immunity Review DecipheringandReversingTumorImmuneSuppression

  year unknowncites this paper
• Title : Deciphering and reversing tumor immune suppression

  year unknowncites this paper